Comparative pharmacology and toxicology of tramadol and tapentadol

被引:63
|
作者
Faria, J. [1 ,2 ,3 ,4 ]
Barbosa, J. [1 ,2 ,3 ,4 ]
Moreira, R. [1 ]
Queiros, O. [1 ]
Carvalho, F. [2 ]
Dinis-Oliveira, R. J. [1 ,2 ,3 ,4 ]
机构
[1] Univ Inst Hlth Sci IUCS, Inst Res & Adv Training Hlth Sci & Technol, IINFACTS, Dept Sci,CESPU,CRL, Gandra, Portugal
[2] Univ Porto, UCIBIO REQUIMTE, Fac Pharm, Lab Toxicol,Dept Biol Sci, Porto, Portugal
[3] Univ Porto, Fac Med, Dept Publ Hlth & Forens Sci, Porto, Portugal
[4] Univ Porto, Fac Med, Med Educ, Porto, Portugal
关键词
ATYPICAL OPIOID TAPENTADOL; PAIN MANAGEMENT; BLOOD-PRESSURE; RESPIRATORY DEPRESSION; N-DESMETHYLTAPENTADOL; LIQUID-CHROMATOGRAPHY; EXTENDED-RELEASE; RECEPTOR AGONIST; CEREBRAL-CORTEX; NONMEDICAL USE;
D O I
10.1002/ejp.1196
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Moderate-to-severe pain represents a heavy burden in patients' quality of life, and ultimately in the society and in healthcare costs. The aim of this review was to summarize data on tramadol and tapentadol adverse effects, toxicity, potential advantages and limitations according to the context of clinical use. We compared data on the pharmacological and toxicological profiles of tramadol and tapentadol, after an extensive literature search in the US National Library of Medicine (PubMed). Tramadol is a prodrug that acts through noradrenaline and serotonin reuptake inhibition, with a weak opioid component added by its metabolite O-desmethyltramadol. Tapentadol does not require metabolic activation and acts mainly through noradrenaline reuptake inhibition and has a strong opioid activity. Such features confer tapentadol potential advantages, namely lower serotonergic, dependence and abuse potential, more linear pharmacokinetics, greater gastrointestinal tolerability and applicability in the treatment of chronic and neuropathic pain. Although more studies are needed to provide clear guidance on the opioid of choice, tapentadol shows some advantages, as it does not require CYP450 system activation and has minimal serotonergic effects. In addition, it leads to less side effects and lower abuse liability. However, invivo and invitro studies have shown that tramadol and tapentadol cause similar toxicological damage. In this context, it is important to underline that the choice of opioid should be individually balanced and a tailored decision, based on previous experience and on the patient's profile, type of pain and context of treatment. SignificanceThis review underlines the need for a careful prescription of tramadol and tapentadol. Although both are widely prescribed synthetic opioid analgesics, their toxic effects and potential dependence are not completely understood yet. In particular, concerning tapentadol, further research is needed to better assess its toxic effects.
引用
收藏
页码:827 / 844
页数:18
相关论文
共 50 条
  • [1] Comparative metabolism of tramadol and tapentadol: a toxicological perspective
    Barbosa, Joana
    Faria, Juliana
    Queiros, Odilia
    Moreira, Roxana
    Carvalho, Felix
    Dinis-Oliveira, Ricardo Jorge
    DRUG METABOLISM REVIEWS, 2016, 48 (04) : 577 - 592
  • [2] Comparative toxicity of tramadol and tapentadol in Wistar rats
    Barbosa, J.
    Faria, J.
    Queiros, O.
    Moreira, R.
    Carvalho, F.
    Dinis Oliveira, R.
    TOXICOLOGY LETTERS, 2016, 258 : S103 - S103
  • [3] Mechanistic and functional differentiation of tapentadol and tramadol
    Raffa, Robert B.
    Buschmann, Helmut
    Christoph, Thomas
    Eichenbaum, Gary
    Englberger, Werner
    Flores, Christopher M.
    Hertrampf, Torsten
    Koegel, Babette
    Schiene, Klaus
    Strassburger, Wolfgang
    Terlinden, Rolf
    Tzschentke, Thomas M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1437 - 1449
  • [4] Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats
    Dominguez-Oliva, Adriana
    Casas-Alvarado, Alejandro
    Miranda-Cortes, Agatha Elisa
    Hernandez-Avalos, Ismael
    JOURNAL OF ADVANCED VETERINARY AND ANIMAL RESEARCH, 2021, 8 (03) : 404 - 422
  • [5] THE PIGEON AS A MODEL FOR COMPARATIVE BEHAVIORAL PHARMACOLOGY AND TOXICOLOGY
    MCMILLAN, DE
    NEUROTOXICOLOGY AND TERATOLOGY, 1990, 12 (05) : 523 - 529
  • [6] Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System
    Tsutaoka, Ben T.
    Ho, Raymond Y.
    Fung, Stacey M.
    Kearney, Thomas E.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (12) : 1311 - 1316
  • [7] The pharmacology of tramadol
    Dayer, P
    Desmeules, J
    Collart, L
    DRUGS, 1997, 53 (Suppl 2) : 18 - 24
  • [8] THE PHARMACOLOGY OF TRAMADOL
    DAYER, P
    COLLART, L
    DESMEULES, J
    DRUGS, 1994, 47 : 3 - 7
  • [9] Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells
    Faria, Juliana
    Barbosa, Joana
    Queiros, Odilia
    Moreira, Roxana
    Carvalho, Felix
    Dinis-Oliveira, Ricardo Jorge
    TOXICOLOGY, 2016, 359 : 1 - 10
  • [10] Tapentadol vs tramadol: Comparative toxicity utilizing data reported to the National Poison Data System
    Tsutaoka, Ben
    Ho, Raymond
    Kearney, Thomas
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 669 - 669